UPDATE: Oppenheimer Downgrades Vanda Pharmaceuticals (VNDA) to Underperform
Tweet Send to a Friend
(Updated - March 16, 2020 6:37 AM EDT)
(updated to add analyst comments)Oppenheimer analyst Esther Rajavelu downgraded Vanda Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Oppenheimer analyst Esther Rajavelu downgraded Vanda Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
